Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer

ATASOY B. M., ABACIOGLU M. U., Dane F., Ozgen Z., Yumuk P. F., Ozden S., ...More

JOURNAL OF BUON, vol.12, no.2, pp.203-208, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 2
  • Publication Date: 2007
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.203-208
  • Keywords: concomitant chemoradiotherapy, oral fluoropyrimidine, rectal cancer, survival, toxicity, UFT, ORAL LEUCOVORIN, PHASE-III, FLUOROURACIL, CHEMOTHERAPY, THERAPY, UFT, MULTICENTER, TRIAL
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No


Purpose: We report the feasibility and toxicity profile, and the impact on local control, disease-free survival and overall survival rates of our study which consisted of postoperative concurrent chemoradiotherapy, followed by adjuvant chemotherapy using uracil-tegafur (UFT)/leukovorin (L V) in locally advanced rectal cancer patients.